Provided by Tiger Trade Technology Pte. Ltd.

Vera Therapeutics, Inc.

33.33
+3.9013.25%
Post-market: 33.550.2194+0.66%19:49 EST
Volume:3.20M
Turnover:104.14M
Market Cap:2.13B
PE:-8.33
High:34.07
Open:29.10
Low:28.81
Close:29.43
52wk High:51.27
52wk Low:18.53
Shares:63.93M
Float Shares:42.92M
Volume Ratio:2.66
T/O Rate:7.46%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.9990
EPS(LYR):-2.7500
ROE:-73.25%
ROA:-38.12%
PB:5.34
PE(LYR):-12.12

Loading ...

Vera Therapeutics Announces ORIGIN 3 Late-Breaking Abstract Selected as Featured Oral Presentation at Opening Plenary Session of ASN Kidney Week 2025

GlobeNewswire
·
Oct 17

Vera Therapeutics' Lead Kidney Drug Poised For 2026 Launch In Multi-Billion-Dollar Market

Benzinga_recent_news
·
Oct 17

Vera Therapeutics Poised for Strong Upside on 'Rare' Autoimmune Drug Opportunity, BofA Says

MT Newswires Live
·
Oct 17

BofA Securities Initiates Coverage on Vera Therapeutics With Buy Rating, $31 Price Target

MT Newswires Live
·
Oct 16

Vera Therapeutics Initiated at Buy by B of A Securities

Dow Jones
·
Oct 16

Vera Therapeutics initiated with a Buy at BofA

TIPRANKS
·
Oct 16

Cantor Fitzgerald Keeps Their Buy Rating on Vera Therapeutics (VERA)

TIPRANKS
·
Oct 14

Vera Therapeutics Announces New Inducement Compensation Plan for Twenty One Employees

Reuters
·
Oct 11

Vera Therapeutics (VERA) Receives a Buy from Evercore ISI

TIPRANKS
·
Oct 02

KDIGO guidelines positive for Vera Therapeutics, says Cantor Fitzgerald

TIPRANKS
·
Sep 19

Vera Therapeutics (VERA) Stock Surges 27% Over Last Month

Simply Wall St.
·
Sep 11

Vera Therapeutics Announces Inducement Grants to New Employees Under 2024 Inducement Plan

Reuters
·
Sep 06

Vera Therapeutics Unveils New Employee Compensation Plan with Inducement Stock Options and RSUs

Reuters
·
Aug 09

Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
Aug 09

Stock Track | Vera Therapeutics (VERA) Plummets 5.96% as Q2 Losses Widen, Misses EPS Estimates

Stock Track
·
Aug 06

Vera Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 06

BRIEF-Vera Therapeutics Files For Offering Of Up To $200 Million Class A Common Stock - Filing

Reuters
·
Aug 06

Vera Therapeutics Inc. Enters New $200 Million Sales Agreement with TD Cowen, Replacing 2022 Agreement

Reuters
·
Aug 06

Vera Therapeutics Files for Offering of up to $200 Mln Class a Common Stock - Filing

THOMSON REUTERS
·
Aug 06

Earnings Flash (VERA) Vera Therapeutics Posts Q2 Net Loss $1.20, vs. FactSet Est of $0.82 Loss

MT Newswires Live
·
Aug 05